Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Dry Eye Syndrome”

Showing 16 of 0 results

Not applicableStudy completedNCT06189456
What this trial is testing

Evaluation of Performance and Safety of Eye Drops With Hyaluronic Acid 0.30% and 0.15%

Who this might be right for
Dry Eye Syndrome (DES)
Fidia Farmaceutici s.p.a. 101
Testing effectiveness (Phase 2)Study completedNCT06435182
What this trial is testing

Study of OT202 in Treating Moderate to Severe Dry Eye

Who this might be right for
Dry Eye
Ocumension Therapeutics (Shanghai) Co., Ltd 213
Testing effectiveness (Phase 2)Study completedNCT00349466
What this trial is testing

Safety and Efficacy Study of CF101 to Treat Keratoconjunctivitis Sicca

Who this might be right for
Keratoconjunctivitis Sicca
Can-Fite BioPharma 80
Testing effectiveness (Phase 2)Study completedNCT03676335
What this trial is testing

Assess the Safety and Efficacy of CsA Ophthalmic Gel in Subjects With Dry Eye

Who this might be right for
Dry Eye
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. 240
Not applicableUnknownNCT04096898
What this trial is testing

Senofilcon A Lenses in Moderate to Severe Dry Eye Disease

Who this might be right for
Moderate to Severe Dry Eye Disease
University of Illinois at Chicago 32
Testing effectiveness (Phase 2)Study completedNCT07264517
What this trial is testing

Evaluating the Safety, Tolerability, and Efficacy of GRF312 5% in Participants With Dry Eye Disease (DED).

Who this might be right for
Dry Eye Disease
Instituto Grifols, S.A. 103
Not applicableUnknownNCT05131152
What this trial is testing

Microvascular and Inflammatory Responses of 0.05 Cyclosporine Eye Drop (II) in Treatment of Dry Eye

Who this might be right for
Dry Eye
Zhongshan Ophthalmic Center, Sun Yat-sen University 100
Large-scale testing (Phase 3)UnknownNCT05245604
What this trial is testing

Evaluating the Efficacy and Safety of TJO-087 in Moderate to Severe Dry Eye Disease Patients

Who this might be right for
Dry Eye Syndrome
Taejoon Pharmaceutical Co., Ltd. 182
Post-approval studies (Phase 4)Study completedNCT01742884
What this trial is testing

Efficacy and Safety of a Treatment for Dry Eye Syndrome: Thealoz

Who this might be right for
Moderate Dry Eye Syndrome
Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA 50
Not applicableStudy completedNCT06375499
What this trial is testing

Performance and Safety of T2769 Versus Hylo-Forte® in the Treatment of Moderate to Severe Dry Eye Syndrome.

Who this might be right for
Dry Eye Syndrome
Laboratoires Thea 74
Not applicableLooking for participantsNCT07593885
What this trial is testing

Evaluate the Performance and Safety of Artelac® Complete MDO® Versus VISMED® MULTI Eye Drops in the Management of Moderate to Severe Dry Eye Disease

Who this might be right for
Dry Eye
Dr. Gerhard Mann chem.-pharm. Fabrik GmbH 160
Not applicableStudy completedNCT06607237
What this trial is testing

Evaluation of Safety and Efficacy of DM-28 for Treatment of Moderate to Severe Ocular Dryness

Who this might be right for
Dry Eye
Horus Pharma 44
Post-approval studies (Phase 4)Study completedNCT03608761
What this trial is testing

Comparison Between Rebamipide 2% Versus Autologous Serum

Who this might be right for
Dry Eye SyndromesSjögren Syndrome
Hospital Nacional Profesor Alejandro Posadas 21
Not applicableUnknownNCT02424266
What this trial is testing

Three Dimension Tomography of Eye Structures by White Light Imaging Device

Who this might be right for
Healthy SubjectsModerate to Severe Keratoconjunctivitis Sicca (KCS)Dry Eye Syndrome (DES)
Meir Medical Center 60
Not applicableStudy completedNCT03709641
What this trial is testing

Evaluate the Safety and Effectiveness of Restylane-Defyne for Punctual Occlusion

Who this might be right for
Mild to Moderate Dry Eye Disease
John C Meyer, MD 14
Large-scale testing (Phase 3)UnknownNCT06291194
What this trial is testing

Efficacy and Safety of AJU-S56 5% in Dry Eye Syndrome Patients

Who this might be right for
Dry Eye Syndromes
AJU Pharm Co., Ltd. 396

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation